Management of eclampsia in the accident and emergency department
|
|
- Gervase Morrison
- 6 years ago
- Views:
Transcription
1 J Accid Emerg Med 2000;17: Department of Accident and Emergency Medicine, Southern General Hospital, 1345 Govan Road, Glasgow G51 4TF Correspondence to: Dr Munro ( pmunro@netcomuk.co.uk) Accepted 28 September 1999 Management of eclampsia in the accident and emergency department Philip T Munro Abstract Eclampsia is defined as the occurrence of seizures in pregnancy or within 10 days of delivery, accompanied by at least two of the following features documented within 24 hours of the seizure: hypertension, proteinuria, thrombocytopenia or raised aspartate amino transferase. Eclampsia complicates approximately one in 2000 pregnancies in the United Kingdom and it remains one of the main causes of maternal death. Up to 38% of cases of eclampsia can occur without premonitory signs or symptoms of pre-eclampsia that is, hypertension, proteinuria, and oedema. Only 38% of eclamptic seizures occur antepartum; 18% occur during labour and a further 44% occur postpartum. Rare cases of eclampsia have occurred over a week after delivery. Outcome is poor for mother and child. Almost one in 50 women suvering eclamptic seizures die, 23% will require ventilation and 35% will have at least one major complication including pulmonary oedema, renal failure, disseminated intravascular coagulation, HELLP syndrome, acute respiratory distress syndrome, stroke, or cardiac arrest. Stillbirth or neonatal death occurs in approximately one in 14 cases of eclampsia. Up to one third of eclamptic seizures occur out of hospital. For this reason, initial management may involve accident and emergency departments. Early involvement of senior obstetric stav is crucial. Optimal emergency management of seizures, hypertension, fluid balance and subsequent safe transfer is essential to minimise morbidity and mortality. (J Accid Emerg Med 2000;17:7 11) Keywords: eclampsia; magnesium sulphate; seizures; pregnancy Eclampsia, meaning literally to shine forth, complicates approximately one in 2000 pregnancies and is one of the main causes of maternal death in the United Kingdom. 1 The cause is a pregnancy specific, underlying multiorgan disorder involving vascular endothelial damage, intravascular coagulation, and vasoconstriction leading to end organ ischaemia. There may be a variety of presentations and classic features are not always present. Changes have occurred in the recommended treatment for eclamptic seizures and are considerably diverent from other seizure disorders (including management of hypertension and careful fluid balance). As one third of cases occur out of hospital, eclampsia should be considered in the diverential diagnosis in any pregnant woman presenting to the accident and emergency (A&E) department with seizures. Definition An early definition of eclampsia was the occurrence of seizures in the presence of preeclampsia (shown by hypertension, proteinuria, and oedema occurring after 20 weeks gestation). Current definitions place less reliance on the presence of pre-eclampsia as eclampsia can develop without preceding symptoms or signs in up to 38% of cases. 2 The UK Eclampsia Trial 1 definition consisted of: Seizures occurring in pregnancy or within 10 days of delivery and with at least two of the following features documented within 24 hours of the seizure: x Hypertension diastolic blood pressure (DBP) of at least 90 mm Hg (if DBP less than 90 mm Hg on booking visit) or DBP increment of 25 mm Hg above booking level. x Proteinuria one plus or at least 0.3 g/24 h. x Thrombocytopenia less than /µl. x Raised aspartate amino transferase (AST) greater than 42 IU/l. Pre-eclampsia is a pregnancy specific, multiorgan disorder. The main features are hypertension, proteinuria, and generalised oedema occurring after 20 weeks gestation. Other common features include haemoconcentration, hypoalbuminaemia, hepatic dysfunction, coagulation problems and hyperuricaemia. Pre-eclampsia usually regresses within 48 hours of delivery. Hypertension in this setting is usually taken as DBP 15 mm Hg higher than DBP in early pregnancy. If previous values are not known, a blood pressure of greater than140/90 mm Hg is considered significant. Table 1 shows indicators of severe preeclampsia. Pre-eclampsia may progress to eclamptic seizures without warning, although the above features may herald the onset of fits. Table 1 Indicators of severe pre-eclampsia + Systolic blood pressure >160 mm Hg + DBP >110 mm Hg + Proteinuria ++ or Serum creatinine >1.2 mg/dl + Platelets < /µl + Increased AST or ALT + Epigastric pain + Headache, other cerebral or visual symptoms + Retinal exudates, haemorrhages, or papilloedema + Pulmonary oedema
2 8 Munro Incidence A prospective descriptive survey of every case of eclampsia in the UK was carried out in Two hundred and seventy nine consultant led obstetric units were surveyed. Five hundred and eighty two possible cases were reported and 383 were subsequently confirmed as cases of eclampsia. This gave a rate of 4.9 per maternities. This incidence is similar to that reported in the USA in of 4.3 per Sixty eight per cent of seizures occurred in hospital; 44% were postpartum; 18% were intrapartum. The remainder were antepartum. Of the postpartum cases, 20 seizures occurred more than 48 hours after delivery and three occurred after seven days. Pathophysiology Pre-eclampsia/eclampsia is thought to result from abnormal placental development. Major pathological changes occur in the placental vascular bed resulting in placental ischaemia. An alteration in the ratio of prostacyclin and thromboxane occurs along with platelet aggregation, thrombin activation, and fibrin deposition in maternal systemic vascular beds. Increased capillary permeability and hypoalbuminaemia also occur. A combination of profound vasospasm and thrombosis causes dysfunction of almost all organ systems. 2 Pre-disposing factors for pre-eclampsia include nulliparity, multiple gestations, extremes of age (teenagers three times more likely than older women), diabetes mellitus, hydatidiform mole, fetal hydrops, and family history. 1 4 In pre-eclampsia, there are exaggerated responses to angiotensin II, catecholamines, and vasopressin. 2 Intravascular volume is reduced. Seizures are thought to be the result of cerebral vasospasm and endothelial damage leading to ischaemia, microinfarcts, and oedema. 2 5 Bleeding time is frequently increased in severe pre-eclampsia, although standard coagulation tests such as prothrombin time and partial thromboplastin time may be normal. 2 The cause of this is uncertain but increased levels of von Willebrand s factor and other unknown substances may be implicated. 6 Presentation of eclampsia In the UK Eclampsia Trial, 1 18% of women suvering eclamptic seizures were parous and had no previous history of pre-eclampsia or eclampsia. Seizures were significantly more likely in teenagers and those with multiple pregnancies that is, twins, triplets, etc. Making a diagnosis of pre-eclampsia in the A&E department may be diycult as the features of hypertension, proteinuria, and oedema can occur individually as part of other diseases and in normal pregnancy. 4 Table 2 summarises the incidence of proteinuria, hypertension, and symptoms before the onset of seizure. Thirty eight per cent had their first fit outside the hospital and 49% of women with eclampsia had multiple seizures. A recent case series suggested that all women at more than 20 weeks gestation presenting with epigastric or right Table 2 Presentation of eclampsia (UK Eclampsia Trial) 1 Features documented at most recent antenatal visit + Proteinuria alone 10% + Hypertension alone 22% + Proteinuria and hypertension 57% + Neither proteinuria or hypertension 11% Symptoms preceding seizure (occurred in 59% of cases) + Headache 50% + Visual disturbances 19% + Epigastric pain 19% + Alloftheabove 4% Table 3 DiVerential diagnosis of seizures in pregnancy Primary generalised epilepsy Subarachnoid haemorrhage Hypoglycaemia Thrombotic thrombocytopenic purpura Amniotic fluid embolism Central venous sinus thrombosis Water intoxication Phaeochromocytoma Local anaesthetic toxicity (for example, epidural) Overdose (for example, tricyclic antidepressants) Table 4 Complications of eclampsia (n=383) (%) Required ventilation 87 (23) Disseminated intravascular coagulation (not 33 (9) HELLP) HELLP 27 (7) Renal failure 24 (6) Pulmonary oedema 18 (5) Acute respiratory distress syndrome 7 (1.8) Cerebrovascular accident 7 (1.8) Cardiac arrest 6 (1.6) Death 7 (1.8) upper quadrant pain should have their blood pressure checked and urine analysis performed. 7 Table 3 details the diverential diagnosis of seizures in pregnancy. Complications In the UK Eclampsia Trial, 1 1.8% of patients died and 35% had at least one major complication (see table 4). Preterm and antenatal eclampsia seem to be the most severe. Stillbirth and neonatal death rates were 22.2 and 34.1 per 1000 deliveries respectively. Overall, one in 14 ovspring of women with eclampsia died. In the UK, cerebral haemorrhage is the most common cause of death in eclampsia and pre-eclampsia The cerebral manifestations are similar to hypertensive encephalopathy with thrombosis and fibrinoid necrosis of cerebral arterioles, divuse microinfarcts, and petechial haemorrhages in the brain However, approximately 20% of women with eclampsia have a systolic blood pressure of less than 140 mm Hg or a DBP of less than 90 mm Hg around the time of the seizure. 11 Retinal changes of hypertensive encephalopathy are rarely seen. 2 As intravascular volume depletion is accompanied by intense vasospasm, these patients are at increased risk of pulmonary oedema from excessive fluid replacement. Conversely, they are at risk of hypovolaemia even from the normal blood loss associated with delivery. 2 Pulmonary oedema may be attributable to a combination of increased capillary permeability, low colloid osmotic pressure, and pulmonary endothelial damage. Renal complications
3 Management of eclampsia 9 Table 5 Immediate management of eclampsia + Summon senior A&E and obstetric stav + Secure airway and administer high flow oxygen + Place wedge under right hip or nurse in left lateral position + Secure intravenous access and draw blood for FBC, U&Es, LFTs, clotting screen, cross match, and Kleihauer test if abruption suspected + Control seizures + Control hypertension + Monitor vital signs including BP, ECG, RR, SaO 2 and fetal heart rate + Catheterise bladder, monitor urine output, and test urine for protein Table 6 Drug treatment in eclampsia 4 Drug Dose Onset Side evects Seizure control Diazepam or Lorazepam 5 10 mg slow iv bolus 2 4 mg slow iv bolus Magnesium 4 6 g slow iv bolus Loss of patellar reflexes sulphate over 5 minutes then Drowsiness 1 2 g/h iv infusion Slurring of speech Flushing Muscle weakness Respiratory depression Blood pressure control Hydralazine 5 mg slow iv bolus 10 min Headache, tremor, nausea, every min vomiting, tachycardia or Labetalol 10 mg slow iv bolus 5 10 min Bradycardia (fetal), Fluids Crystalloid iv=intravenous. doubling every min to max 300 mg total or 1 2 mg/min iv infusion 1 2 ml/kg/h with monitoring of urine output maternal flushing, nausea Table 7 The Collaborative Eclampsia Trial 18 Complications Magnesium sulphate (%) Diazepam (%) Significance include glomerular swelling and fibrin deposition resulting in glomerular capillary endotheliosis. Oliguria is common and this can progress to acute tubular necrosis. 2 Hepatic dysfunction may result from periportal hepatic necrosis, subcapsular haemorrhages or fibrin deposition in hepatic sinusoids. In very rare cases, fatal hepatic rupture may occur. 2 Hepatic dysfunction may form part of the HELLP syndrome, which complicates 0.3% of all pregnancies and up to 20% of women with severe pre-eclampsia. The syndrome comprises haemolysis, increased liver enzymes, and low platelets with epigastric or right upper quadrant pain. 12 This represents a life threatening complication and requires prompt delivery. Disseminated intravascular coagulation occurs in 7% of patients with eclampsia but the cause is unclear. 2 Fetal complications are thought to arise as a result of placental hypoperfusion. These include high fetal loss rate, intrauterine growth retardation, small for dates infants and increased perinatal mortality. The oxyhaemoglobin dissociation curve is shifted to the left in pre-eclampsia, reducing oxygen delivery to the fetus. 2 Placental abruption may accompany eclampsia. Aims of treatment Management of pre-eclampsia/eclampsia consists of prevention or treatment of seizures, control of blood pressure and ultimately, delivery of the infant Table 5 summarises immediate management of eclampsia. Sixty per cent of maternal deaths in this condition are attributable to cerebral haemorrhage and a blood pressure of more than 170/110 mm Hg should be treated urgently but maintained above 130/90 mm Hg to avoid acute reduction of placental perfusion. 4 Delivery is indicated urgently if there is evidence of severe, progressive disease such as headache, blurred vision, scotomata, epigastric pain, DBP greater than 110 mm Hg, clonus, coagulopathy, raised creatinine, or liver enzymes. 4 Table 6 summarises drug treatment of eclampsia. CONTROL OF SEIZURES Previous studies in the UK reported diazepam and phenytoin as the drugs of choice for treatment of eclamptic seizures Both were commonly used and evective in the treatment of other forms of seizure and phenytoin had the advantage of having little sedative evect. First line measures to control seizures remain diazepam or diazemuls 5 10 mg, or lorazepam 2 4 mg given as a slow intravenous bolus. Chlormethiazole has largely been abandoned because of risks of oversedation, loss of airway reflexes, respiratory depression, and fluid overload. By comparison, magnesium sulphate has been first line treatment in the USA and South Africa for many years and is gaining acceptance as the treatment of choice in the UK The Collaborative Eclampsia Trial 19 was an international multicentre randomised trial involving 1680 women with eclampsia. The trial was divided into two arms. The first compared magnesium sulphate with diazepam and the second compared magnesium sulphate with phenytoin in the prevention of recurrent seizures. Maternal and neonatal morbidity and mortality were the outcome measures. Table 7 summarises the results. This study concluded that magnesium sulphate should be the drug of choice for eclampsia. Phenytoin appeared to cause more Magnesium sulphate (%) Phenytoin (%) Significance Recurrent fits S S Maternal mortality NS NS Perinatal mortality NS NS Ventilation NS S Respiratory depression NS NS Pneumonia NS S ITU admission NS S Blood transfusion NS S Neonatal intubation NS S SCBU admission NS S NS = non-significant, S = significant.
4 10 Munro maternal and neonatal morbidity and diazepam and phenytoin were associated with increased recurrence of seizures compared with magnesium sulphate. Magnesium sulphate does not seem to be an anticonvulsant but is known to be a potent cerebral vasodilator. It is thought to reverse cerebral vasoconstriction by blocking calcium influx through the NMDA (N-methyl-Daspartate) subtype of the glutamate channel. 2 Two prospective, randomised, controlled trials using cranial Doppler ultrasound examination of cerebral blood flow have supported this explanation. Magnesium sulphate may also have a role in the prophylaxis of seizures in pre-eclampsia. 22 Magnesium sulphate is administered in a loading dose of 4 to 6 g given as a slow intravenous bolus (for example, four 2 ml ampoules of 50% solution made up to 20 ml with 5% dextrose or sterile water, given over five minutes). This loading dose should be followed by a maintenance infusion of 1 to 2 g per hour. The patient should be monitored carefully for clinical signs of magnesium toxicity, particularly loss of patellar reflexes, drowsiness, flushing, slurring of speech, muscle weakness and respiratory depression, which may herald respiratory (or cardiorespiratory) arrest. Level of consciousness, respiratory rate and evort and the presence of patellar reflexes should be frequently and regularly recorded during the infusion. If toxicity is suspected, the infusion should be discontinued and if required, calcium gluconate (10 ml of 10% solution) should be given. Magnesium sulphate increases sensitivity to non-depolarising neuromuscular blocking agents such as vecuronium. Fasciculations may not occur after suxamethonium. 2 CONTROL OF BLOOD PRESSURE Hydralazine is known to be evective for controlling hypertension in pre-eclampsia/ eclampsia. 11 After an intravenous bolus, evects are seen by 10 minutes and are maximal by 20 minutes. Its duration of action is six to eight hours. Side evects include hypotension, tachycardia, tremor, headache, nausea, and vomiting. Unfortunately, this may mimic impending eclampsia. Neonatal thrombocytopenia has also been reported in association with the use of hydralazine. Labetalol is being used more frequently in this setting. Its onset of action is more rapid than hydralazine, reflex tachycardia does not occur and there are few maternal or neonatal side evects. It was found to safely lower mean arterial pressure in a randomised controlled double blind trial of 152 women with pregnancy induced hypertension. 23 Under invasive blood pressure monitoring, blood pressure should be controlled aiming for a DBP of 90 to 100 mm Hg. Give hydralazine 5 mg slow intravenous bolus and repeat every 20 to 30 minutes as indicated, or, give labetalol 10 mg slow intravenous bolus, doubling the dose every 10 minutes (for example, 10, 20, 40, etc to a maximum total of 300 mg) or start an intravenous infusion of 1 2 mg/min until the required DBP is reached. FLUID MANAGEMENT Pre-eclampsia/eclampsia seems to be a high cardiac output state associated with an inappropriately high peripheral resistance. It is also associated with haemoconcentration, reduction and central redistribution of plasma volume. 24 Volume expansion seems to produce transient benefit but there are no studies to suggest that this is accompanied by reduced maternal or fetal morbidity or mortality. 2 Controversy exists as to whether central venous pressure monitoring is helpful as it may not accurately reflect pulmonary capillary wedge pressure. Most cases are managed without such monitoring. One study, using invasive monitoring in 49 patients with severe preeclampsia, demonstrated normal or high cardiac output in the presence of normal wedge and central venous pressure, and inappropriately high systemic vascular resistance. 24 It concluded, that because filling pressures were normal, fluid should be given cautiously to avoid precipitating pulmonary oedema. Hypotension and fetal distress have been reported in pre-eclamptic patients given epidural analgesia or hydralazine without prior fluids. In view of the increased risk of pulmonary oedema, a suggested fluid regimen is of crystalloids given at 1 2 ml/kg/h with careful monitoring of urine output. 2 4 URGENT TRANSFER Arrange urgent transfer to an obstetric unit for delivery. Conclusion Eclampsia remains a major cause of maternal and fetal morbidity and mortality in the UK. Up to one third of cases may present to the A&E department. A variety of presentations may occur. The diagnosis needs to be considered in any patient at more than 20 weeks gestation with any suspicious features. Prompt recognition and appropriate management minimises morbidity and mortality for both mother and child. In view of recent changes in the treatment of eclampsia, A&E departments, together with their local obstetricians, should review their treatment guidelines and ensure the appropriate drugs are readily available. I thank Mr M Gordon and Dr T Parke for their helpful comments in the preparation of this review. Philip Munro initiated, researched, wrote and revised the manuscript and will act as guarantor. Conflict of interest: none. Funding: none. 1 Douglas KA, Redman CWG. Eclampsia in the United Kingdom. BMJ 1994;309: Mushambi MC, Halligan AW, Williamson K. Recent developments in the pathophysiology and management of pre-eclampsia. Br J Anaesth 1996;76: Saftlas AF, Olson DR, Franks AL, et al. Epidemiology of pre-eclampsia and eclampsia in the United States, Am J Obstet Gynecol 1990;163: Probst BD. Hypertensive disorders of pregnancy. Emerg Med Clin North Am 1994;12: Brown CEL, Purdy P, Cunningham FG. Head computed tomographic scans in women with eclampsia. Am J Obstet Gynecol 1988;159: Kupfeminc MJ, Eldor A, Steinman N, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999;340:9 13.
5 Management of eclampsia 11 7 Barry C, Fox R, Stirrat G. Upper abdominal pain in pregnancy may indicate pre-eclampsia. BMJ 1994;308: Department of Health, Welsh OYce, Scottish OYce Home into maternal deaths in the United Kingdom London: HMSO, Department of Health, Welsh OYce, Scottish OYce Home into maternal deaths in the United Kingdom London: HMSO, Department of Health, Welsh OYce, Scottish OYce Home into maternal deaths in the United Kingdom London: HMSO, National high blood pressure education program working group report on high blood pressure in pregnancy. Am J Obstet Gynecol 1990;163: Weinstein L. Syndrome of hemolysis, elevated liver enzymes, low platelet count: a severe consequence of hypertension on pregnancy. Am J Obstet Gynecol 1982;142: Abbott JT. Acute complications related to pregnancy. In: Rosen P, Barkin R, eds. Emergency medicine: concepts and clinical practice. 4th Ed. St Louis: Mosby, Hansen WF, Hansen AR. Problems in pregnancy. In: Tintinalli JE, Ruis E, Krome RL, eds. Emergency medicine: a comprehensive study guide. 4th Ed. New York: McGraw-Hill, Nash P, Price J. Obstetric emergencies. In: Skinner D, Swain A, Peyton R, et al. Cambridge textbook of accident and emergency medicine. Cambridge: Cambridge University Press, Hutton JD, James DK, Stirrat GM, et al. Management of severe pre-eclampsia and eclampsia by UK consultants. Br J Obstet Gynaecol 1992;99: Gulmezoglu AM, Duley L. Use of anticonvulsants in eclampsia and pre-eclampsia: survey of obstetricians in the United Kingdom and Republic of Ireland. BMJ 1998;316: Robson SC. Magnesium sulphate: the time of reckoning. Br J Obstet Gynaecol 1996;103: The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995;345: Naidu S, Payne AJ, Moodley J, et al. Randomised study assessing the evect of phenytoin and magnesium sulphate on maternal cerebral circulation in eclampsia using transcranial Doppler ultrasound. Br J Obstet Gynaecol 1996;103: Belfort MA, Moise KJ. EVect of magnesium sulfate on maternal brain blood flow in pre-eclampsia: a randomised, placebo-controlled study. Am J Obstet Gynecol 1992;167: Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl JMed 1995;333: Pickles CJ, Symonds EM, Pipkin FB. The fetal outcome in a randomised double-blind controlled trial of labetalol versus placebo in pregnancy-induced hypertension. Br J Obstet Gynaecol 1989;96: Mabie WC, Ratts TE, Sibai BM. The central hemodynamics of severe preeclampsia. Am J Obstet Gynecol 1989;161: National Horizon Scanning Centre (NHSC) This specialist unit at the University of Birmingham provides advance notice of new and emerging technologies to the Department of Health. The aim is to enable a more coherent and coordinated introduction of new healthcare technologies that is, all methods used by health professionals to promote health, prevent and treat disease, improve rehabilitation, and long term care. They include pharmaceuticals, medical devices, diagnostic tests and procedures, surgery, rehabilitation, health promotion activities, service delivery, and organisational issues. If you know of any new or emerging technologies that could be important to the NHS you should let the NHSC know by completing the form on the web site or by writing to: National Horizon Scanning Centre, Department of Public Health and Epidemiology, University of Birmingham, Edgbaston, Birmingham B15 2TT. J Accid Emerg Med: first published as /emj on 1 January Downloaded from on 22 April 2018 by guest. Protected by copyright.
CHAPTER 12 HYPERTENSION IN SPECIAL GROUPS HYPERTENSION IN PREGNANCY
CHAPTER 12 HYPERTENSION IN SPECIAL GROUPS HYPERTENSION IN PREGNANCY v Mild preeclampsia is managed by close observation of the mother and fetus preferably in hospital. If the diastolic blood pressure remains
More informationPre-eclampsia: key issues. Robin Russell Nuffield Department of Anaesthetics John Radcliffe Hospital Oxford
Robin Russell Nuffield Department of Anaesthetics John Radcliffe Hospital Oxford Antenatal Issues Labour Analgesia Anaesthesia for Delivery High Dependency Care Hypertension systolic >140 mmhg or diastolic
More informationMercy San Juan Medical Center. Preeclampsia and Other Hypertensive Disorders of Pregnancy
SUBJECT: Preeclampsia and Other Hypertensive Disorders of Pregnancy DEPARTMENTS: FBC, Emergency Department PURPOSE: To outline the nursing management of inpatients who have preeclampsia or other hypertensive
More informationYou admitted a previously healthy nullipara at 36 weeks gestation who presented with new-onset periorbital edema and is found to have blood pressure
Preeclampsia Case report You admitted a previously healthy nullipara at 36 weeks gestation who presented with new-onset periorbital edema and is found to have blood pressure readings of 150/100 to 155/105
More informationSEVERE PRE-ECLAMPSIA
DEFINITIONS SEVERE PRE-ECLAMPSIA Pre-eclampsia: pregnancy induced hypertension with significant proteinuria +/- oedema affecting virtually any organ system in the body Severe pre-eclampsia: Diastolic blood
More informationGuideline for Management of Severe or Fulminating Pre-Eclampsia
Guideline for Management of Severe or Fulminating Pre-Eclampsia Originator: Labour Ward Forum, Maternity Services Date Approved: September 2011 Approved by: W&CH Quality & Safety Group Reviewed and ratified
More informationCMQCC Preeclampsia Tool Kit: Hypertensive Disorders Across the Lifespan
CMQCC Preeclampsia Tool Kit: Hypertensive Disorders Across the Lifespan Carol J Harvey, MS, BSN, RNC-OB, C-EFM, CS Northside Hospital Atlanta Cherokee - Forsyth New! Improving Health Care Response to Preeclampsia:
More informationAWHONN Oregon Section 2014
AWHONN Oregon Section 2014 Carol J Harvey, MS, BSN, RNC-OB, C-EFM, CS Northside Hospital Atlanta Cherokee - Forsyth Hypertensive in Pregnancy Carol J Harvey, MS, RNC-OB, C-EFM Clinical Specialist Northside
More informationMANAGEMENT OF HYPERTENSION IN PREGNANCY, THE ALGORHITHM
MANAGEMENT OF HYPERTENSION IN PREGNANCY, THE ALGORHITHM Are Particular Anti-hypertensives More Effective or Harmful Than Others in Hypertension in Pregnancy? Existing data is inadequate Methyldopa and
More informationPreeclampsia. &Eclampsia. Hypertensive Disorders of Pregnancy. What we need to know about. Hypertensive Disorders of Pregnancy.
Preeclampsia &Eclampsia Hypertensive Disorders of Pregnancy Barbara Koop MS, RNC-OB What we need to know about Hypertensive Disorders of Pregnancy Define clinical criteria for: Gestational hypertension,
More informationDrugs used in obstetrics
Drugs used in obstetrics Drugs used in obstetrics Drugs may be used to modify uterine contractions. These include oxytocic drugs used to stimulate uterine contractions both in induction of labour and to
More informationMagnesium Sulfate Prophylaxis in Preeclampsia: Evidence From Randomized Trials
CLINICAL OBSTETRICS AND GYNECOLOGY Volume 48, Number 2, 478 488 Ó 2005, Lippincott Williams & Wilkins Magnesium Sulfate Prophylaxis in Preeclampsia: Evidence From Randomized Trials BAHA M. SIBAI, MD Department
More informationINTRAVENOUS HYDRALAZINE POLICY
PURPOSE INTRAVENOUS HYDRALAZINE POLICY The purpose of this policy is to: provide safe and effective care for women establish a local approach to care that is evidence based and consistent inform good decision
More informationClinical features. Abnormal vasculogenesis and angiogenesis and releasing of antiangiogenic
Clinical features Abnormal vasculogenesis and angiogenesis and releasing of antiangiogenic factors results in Vasospasm Endothelial dysfunction Etiology of various clinical signs and symptoms So, Preeclampsia
More informationBased on 2014 SOGC Guidelines
Based on 2014 SOGC Guidelines 22nd Edition 2015 1 ICH + gestational hypertension by far the biggest cause of direct maternal deaths New stats coming in 2013 OCR 22nd Edition 2015 2 Diastolic 90 mmhg is
More informationPregnancy and Neurological Disorders
Pregnancy and Neurological Disorders Myles Connor NHS Borders and University of Edinburgh, United Kingdom Outline Why is it important? Specific conditions Eclampsia Cerebrovascular disease Epilepsy Idiopathic
More informationPolicy REVISED: 6/30/2016 3:30 PM. Applies To: ObGyn Responsible Department: ObGyn Revised: June 30, 2016
Title: Antihypertensive Treatment for Severe Hypertension During Pregnancy Applies To: ObGyn Responsible Department: ObGyn Revised: June 30, 2016 Policy POLICY STATEMENT: Pregnant or postpartum patients
More informationHypertensive Disorders of Pregnancy Guideline
Hypertensive Disorders of Pregnancy Guideline Approved by: Senior Director of Operations, Women s & Child Health, GNCH/MCH Facility Chief, Obstetrics/Gynecology, GNCH Facility Chief, Obstetrics/Gynecology,
More informationMagnesium Sulphate - Management of Hypertensive Disorders of Pregnancy
1. Purpose Magnesium sulphate is the anticonvulsant of choice for pre-eclampsia prophylaxis and treatment. This clinical guideline outlines the indications, contraindications, administration and monitoring
More informationDr Gorakh Mandrupkar. Reaching unreached FOGSI 2010 Initiative 1
Dr Gorakh Mandrupkar In charge, High Risk pregnancy unit, Prakash Memorial Clinic and Research Center,Islampur Member,Young Talent Promotion Committee,FOGSI drmango@rediffmail.com Reaching unreached FOGSI
More informationMagnesium sulfate has an antihypertensive effect on severe pregnancy induced hypertension
Hypertension Research In Pregnancy 11 S. Takenaka et al. ORIGINAL ARTICLE Magnesium sulfate has an antihypertensive effect on severe pregnancy induced hypertension Shin Takenaka 1, Ryu Matsuoka 2, Daisuke
More informationStroke in Pregnancy. Stroke in Pregnancy 6/23/13
G5#$#Preven*ng#Maternal#Morbidity#and#Mortality#Via# Expanded#Scope#of#Nursing#Prac*ce#As#First#Responder# in#hypertensive#crisis#of#preeclampsia# The$presenter$reports$no$relevant,$influencing$financial$rela5onships.$
More informationEclampsia. Intrapartum Management of Pre-eclampsia. Mild v. Severe Preeclampsia. Mild v. Severe Preeclampsia
Intrapartum Management of Pre-eclampsia William. M. Gilbert, MD Regional Medical Director, Women Services Sutter Health, Sac-Sierra Region & Professor of OB/GYN University of California, Davis Eclampsia
More informationCONTROL OF BLOOD PRESSURE IN PREGNANCY: HOW HIGH IS TOO HIGH? EVELYNE REY, CHU Ste-Justine, Montreal
CONTROL OF BLOOD PRESSURE IN PREGNANCY: HOW HIGH IS TOO HIGH? EVELYNE REY, CHU Ste-Justine, Montreal CONFLICTS OF INTEREST $: None Others: Canadian guidelines, CHIPS CSIM2015 2 LEARNING OBJECTIVES New
More informationSAFE approach. Unresponsive? Shout or call for help. Open Airway. Not Breathing normally? 30 chest compressions. 2 rescue breaths
Basic Life Support Dial 2222 Chin lift, head tilt jaw thrust Look, listen, feel For 10 seconds Rate 100/min *Lateral tilt* SAFE approach Unresponsive? Shout or call for help Open Airway Not Breathing normally?
More informationHST 071. IN SUMMARY PREGNANCY INDUCED HYPERTENSION Classification of Hypertensive Disorders of Pregnancy
Harvard-MIT Division of Health Sciences and Technology HST.071: Human Reproductive Biology Course Director: Professor Henry Klapholz IN SUMMARY Classification of Hypertensive Disorders of Pregnancy HST
More informationDBL MAGNESIUM SULFATE CONCENTRATED INJECTION
DBL MAGNESIUM SULFATE CONCENTRATED INJECTION NAME OF MEDICINE Magnesium Sulfate BP DESCRIPTION DBL Magnesium Sulfate Concentrated Injection is a clear, colourless, sterile solution. Each ampoule contains
More informationAS early as 1906 magnesium sulfate was injected intrathecally
Copyright, 1995, by the Massachusetts Medical Society Volume 333 JULY 27, 1995 Number 4 A COMPARISON OF MAGNESIUM SULFATE WITH FOR THE PREVENTION OF ECLAMPSIA MICHAEL J. LUCAS, M.D., KENNETH J. LEVENO,
More informationMaternal Collapse Guideline
Maternal Collapse Guideline Guideline Number: 664 Supersedes: Classification Clinical Version No: Date of EqIA: Approved by: Date Approved: Date made active: Review Date: 1 Obstetric Written Documentation
More informationHypertensives Emergency and Urgency
Hypertensives Emergency and Urgency Budi Yuli Setianto Cardiology Divisision Department of Internal Medicine Faculty of Medicine UGM Sardjito Hospital Yogyakarta Background USA: Hypertension is 30% of
More information50% Concentrated Injection
NAME OF THE MEDICINE. The molecular weight of the compound is 246.5 and the CAS registry number is 10034-99-8. The molecular formula is MgSO4, 7H2O. DESCRIPTION MAGNESIUM SULFATE HEPTAHYDRATE 50% CONCENTRATED
More informationCOMPARATIVE STUDY OF LOW DOSE MAGNESIUM SULPHATE & PRITCHARD REGIME FOR ECLAMPSIA & IMMINENT ECLAMPSIA
COMPARATIVE STUDY OF LOW DOSE MAGNESIUM SULPHATE & PRITCHARD REGIME FOR ECLAMPSIA & IMMINENT ECLAMPSIA N. S. Kshirsagar, Manisha Laddad, Amit Bafana 1. Professor. Department of Obstetrics & Gynecology,
More informationPreeclampsia: What s old is new again. Gene Chang, MD Maternal Fetal Medicine
Preeclampsia: What s old is new again Gene Chang, MD Maternal Fetal Medicine Objectives Define Preeclampsia Review current guidelines Role of proteinuria Timing of delivery Seizure prevention Severe Hypertension
More informationThe Role of the Anaesthesiologist in the Perioperative Management of Preeclampsia. RA Dyer Interlaken 2017
The Role of the Anaesthesiologist in the Perioperative Management of Preeclampsia RA Dyer Interlaken 2017 6 In preeclampsia - Understanding of pathophysiology Assessment of disease severity Prediction
More informationOriginal Research Article
A COMPARATIVE STUDY OF INTRAVENOUS LABETALOL WITH ORAL ANTIHYPERTENSIVE COMBINATION NIFEDIPINE AND ALPHA-METHYLDOPA IN THE ACUTE MANAGEMENT OF HIGH BLOOD PRESSURE IN SEVERE PREGNANCY-INDUCED HYPERTENSION
More informationComparison of Efficacy and Safety of Intravenous Labetalol Versus Hydralazine for Management of Severe Hypertension in Pregnancy
https://doi.org/10.1007/s13224-017-1053-9 ORIGINAL ARTICLE Comparison of Efficacy and Safety of Intravenous Labetalol Versus Hydralazine for Management of Severe Hypertension in Pregnancy Purvi Patel 1
More informationWHAT FLUIDS AND WHEN
WHAT FLUIDS AND WHEN Fluid and Electrolytes Balance Pregnancy Labor Pathological processes during pregnancy Fluid and Electrolytes Balance Non pregnant woman Water homeostasis is a delicate balance between
More informationCounseling and Long-term Follow up After Gestational Disorders
Counseling and Long-term Follow up After Gestational Disorders Tanya Melnik, MD Assistant Professor, University of Minnesota Sarina Martini, MD Ob/Gyn Resident, PGY4 University of Minnesota Counseling
More informationBy Dr.Asmaa Al sanjary
By Dr.Asmaa Al sanjary Preterm delivery is defined by a birth occurring before 37 completed weeks of gestation. Prematurity is multifactorial and its incidence has increased during the last decade in most
More informationStudy of the role of low dose magnesium Sulphate in Hypertensive Disorders of Pregnancy 1 2
ORIGINAL ARTICLE J Pub Health Med Res 2015;3(2):31-37 Study of the role of low dose magnesium Sulphate in Hypertensive Disorders of Pregnancy 1 2 Shubha C.R. Vailaya, Naveena Kumari M. 1 Chief Consultant
More informationDRUG GUIDELINE. MAGNESIUM SULFATE (Obstetric)
DRUG GUIDELINE MAGNESIUM SULFATE (Obstetric) SCOPE (Area): FOR USE IN: Labour Ward, 5N, HDU, ED and Theatre EXCLUSIONS: Paediatrics (seek Paediatrician advice) and other General Wards SCOPE (Staff): Medical,
More informationHypothermia in Neonates with HIE TARA JENDZIO, DNP(C), RN, RNC-NIC
Hypothermia in Neonates with HIE TARA JENDZIO, DNP(C), RN, RNC-NIC Objectives 1. Define Hypoxic-Ischemic Encephalopathy (HIE) 2. Identify the criteria used to determine if an infant qualifies for therapeutic
More informationACUTE KIDNEY INJURY FOCUS ON OBSTETRICS DONNA HIGGINS, CLINICAL NURSE EDUCATOR, NORTHERN LINCOLNSHIRE HOSPITALS NHS FOUNDATION TRUST
ACUTE KIDNEY INJURY FOCUS ON OBSTETRICS DONNA HIGGINS, CLINICAL NURSE EDUCATOR, NORTHERN LINCOLNSHIRE HOSPITALS NHS FOUNDATION TRUST AIMS & OBJECTIVES Review the functions of the kidney Identify renal
More informationPresentation of hypertensive emergency
Presentation of hypertensive emergency Definitions surrounding hypertensive emergency Hypertension: elevated blood pressure (BP), usually defined as BP >140/90; pathological both in isolation and in association
More informationAgenda. Management of Accelerated Hypertension (Updated in 2017) Salwa Roshdy Prof. of Cardiology Assiut University CardioEgypt 23/2/2017 2/27/2017
Management of Accelerated Hypertension (Updated in 2017) By Salwa Roshdy Prof. of Cardiology Assiut University CardioEgypt 23/2/2017 Agenda Definition of Accelerated HTN Pathophysiology & Etiology Prognosis
More informationBlood products and plasma substitutes
Blood products and plasma substitutes Plasma substitutes Dextran 70 and polygeline are macromolecular substances which are metabolized slowly; they may be used to expand and maintain blood volume in shock
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Acid base balance pregnancy-related changes to, 640 Acquired heart disease, 731 Acute fatty liver of pregnancy (AFLP), 618 Acute kidney
More informationTocolytics. Tocolytics (terbutaline, magnesium sulfate injection) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.30.06 Subject: Tocolytics Page: 1 of 5 Last Review Date: September 15, 2016 Tocolytics Description Tocolytics
More informationMaternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic review
Bain et al. BMC Pregnancy and Childbirth 2013, 13:195 RESEARCH ARTICLE Open Access Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes:
More informationPHYSIOLOGICAL CHANGES IN PREGNANCY AND OBSTETRIC EMERGENCIES
PHYSIOLOGICAL CHANGES IN PREGNANCY AND OBSTETRIC EMERGENCIES Shankari Arulkumaran BSc MSc MD MRCOG Consultant Obstetrician and Gynaecologist St Mary s Hospital Imperial College NHS Trust OVERVIEW Obstetric
More informationDeclaration of conflict of interest
Declaration of conflict of interest Claudio Borghi Lectures fees: Menarini International, Servier International, Recordati International, Ely-Lilly USA, BMS, Boheringer Ingelheim, Novartis Pharma Research
More informationORIGINAL ARTICLE Questionnaire-based study of cerebrovascular complications during pregnancy in Aichi Prefecture, Japan
Hypertension Research Eclampsia and stroke In Pregnancy during pregnancy 40 ORIGINAL ARTICLE Questionnaire-based study of cerebrovascular complications during pregnancy in Aichi Prefecture, Japan Yasumasa
More informationFigure 1. Diagram of the study. Group P = 200 Phenytoin. Group M = 200 MgSO 4. Group A = 175 Preeclampsia. Group B = 25 Eclampsia
Preeclampsia is a prevalent multisystem disorder. It is associated with systolic blood pressure of 140 mmhg and/or diastolic blood pressure of 90 mmhg after 20 weeks of gestation and occurrence of proteinuria
More informationRETIRED: REVIEWED/Revised: 12/14; 10/15; 1/16; 9/16, 10/16, 5/17, 5/18, 9/18
PAGE: 1 of 9 Scope Louisiana Healthcare Connections (LHCC) Medical Department Purpose To provide medical necessity criteria for obstetrical Home Health programs offered by vendors such as Optum Obstetrical
More informationPrinted copies of this document may not be up to date, obtain the most recent version from
Children s Acute Transport Service Clinical Guidelines Septic Shock Document Control Information Author Claire Fraser P.Ramnarayan Author Position tanp CATS Consultant Document Owner E. Polke Document
More informationTitrating Critical Care Medications
Titrating Critical Care Medications Chad Johnson, MSN (NED), RN, CNCC(C), CNS-cc Clinical Nurse Specialist: Critical Care and Neurosurgical Services E-mail: johnsoc@tbh.net Copyright 2017 1 Learning Objectives
More informationDRUG GUIDELINE. HYDRALAZINE (Intravenous severe hypertension in pregnancy)
DRUG GUIDELINE HYDRALAZINE (Intravenous severe hypertension SCOPE (Area): FOR USE IN: Labour Ward, HDU, Theatre and ED EXCLUSIONS: Paediatrics (seek Paediatrician advice) and other general wards. SCOPE
More informationPostpartum hypertension, preeclampsia and eclampsia. Arun Jeyabalan, MD MS University of Pittsburgh
Postpartum hypertension, preeclampsia and eclampsia Arun Jeyabalan, MD MS University of Pittsburgh Confusing concept Preeclampsia only occurs in pregnancy placenta is required Delivery cures preeclampsia
More informationIsolated proteinuria in Chinese pregnant women with pre-eclampsia: Results of retrospective observational study
Biomedical Research 2017; 28 (11): 5162-5166 ISSN 0970-938X www.biomedres.info Isolated proteinuria in Chinese pregnant women with pre-eclampsia: Results of retrospective observational study Jing Cai 1,
More informationNURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS. ACUTE CEREBROVASCULAR ACCIDENT TPA (ACTIVASE /alteplase) FOR THROMBOLYSIS
NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS ACUTE CEREBROVASCULAR ACCIDENT TPA (ACTIVASE /alteplase) FOR THROMBOLYSIS I. Purpose : A. To reduce morbidity and mortality associated
More informationAgonistic Autoantibodies to Angiotensin II Type I Receptor Contributes Partly to Placental Ischemia-Induced Cerebrovascular Abnormalities
Agonistic Autoantibodies to Angiotensin II Type I Receptor Contributes Partly to Placental Ischemia-Induced Cerebrovascular Abnormalities Junie Paula Warrington 1, Fan Fan 1, Babbette B. LaMarca 1, Ralf
More informationMajor Haemorrhage Protocol. Commentary
Hairmyres Hospital Monklands Hospital Wishaw General Hospital Major Haemorrhage Protocol Commentary N.B. There is a separate NHSL protocol for the Management of Obstetric Haemorrhage Authors Dr Tracey
More informationBlood Pressure Management in Acute Ischemic Stroke
Blood Pressure Management in Acute Ischemic Stroke Kimberly Clark, PharmD, BCCCP Clinical Pharmacy Specialist Critical Care, Greenville Health System Adjunct Assistant Professor, South Carolina College
More informationCLINICAL GUIDELINES FOR THE MANAGEMENT OF ECLAMPSIA AND SEVERE PRE-ECLAMPSIA.
CLINICAL GUIDELINES FOR THE MANAGEMENT OF ECLAMPSIA AND SEVERE PRE-ECLAMPSIA. Contents Page No. 1. INTRODUCTION 2 2. PROTOCOL FOR THE MANAGEMENT OF 3 SEVERE PRE-ECLAMPSIA (Inclusion Criteria) 3. IMMEDIATE
More informationCASE 5 - Toy et al. CASE FILES: Obstetrics & Gynecology
z CASE 5 - Toy et al. CASE FILES: Obstetrics & Gynecology A 28-year-old woman is brought into the emergency room with a blood pressure of 60/40. The patient s husband states that she had 2 days of nausea
More informationNifedipine Tocolysis Regime Policy
Document ID: MATY072 Version: 1.0 Facilitated by: Karen Wakelin, ACMM Issue Date: August 2010 Approved by: Maternity Quality Committee Review date: October 2017 Nifedipine Tocolysis Regime Policy Policy
More informationShock is defined as a state of cellular and tissue hypoxia due to : reduced oxygen delivery and/or increased oxygen consumption or inadequate oxygen
Shock is defined as a state of cellular and tissue hypoxia due to : reduced oxygen delivery and/or increased oxygen consumption or inadequate oxygen utilization The effects of shock are initially reversible
More informationResuscitating neonatal and infant organs and preserving function. GI Tract and Kidneys
Resuscitating neonatal and infant organs and preserving function GI Tract and Kidneys Australian and New Zealand Resuscitation Council Joint Guidelines Outline Emphasis on the infant - PICU Kidney Gastrointestinal
More informationBECLOT 500MG. INJECTION Composition : Each ml. contains : Tranexamic Acid I.P. 100mg.
BECLOT 500MG. INJECTION Composition : Each ml. contains : Tranexamic Acid I.P. 100mg. DESCRIPTION Tranexamic acid is a synthetic analog of the amino acid lysine. It is used to treat or prevent excessive
More informationTony L Smith DNP RN ACNP CCRN CFRN EMT-IV Vanderbilt LifeFlight
Treatment of a Stroke patient: A look at how to care for the Stroke patient in the aeromedical setting Tony L Smith DNP RN ACNP CCRN CFRN EMT-IV Vanderbilt LifeFlight Objectives 1. Discuss the assessment
More informationCommunity monitoring of blood pressure and proteinuria Maternity
Community monitoring of blood pressure and proteinuria V3 Page 1 of 5 Community monitoring of blood pressure and proteinuria Maternity 1. Introduction and who the guideline applies to: This guideline applies
More informationUnrestricted. Dr ppooransari fellowship of perenatalogy
Unrestricted Dr ppooransari fellowship of perenatalogy Assessment of severity of hemorrhage Significant drops in blood pressure are generally not manifested until substantial bleeding has occurred, and
More informationEndothelial function is impaired in women who had pre-eclampsia
Endothelial function is impaired in women who had pre-eclampsia Christian Delles, Catriona E Brown, Joanne Flynn, David M Carty Institute of Cardiovascular and Medical Sciences University of Glasgow United
More informationETIOLOGY AND PATHOGENESIS OF HYPOXIC-ISCHEMIC ENCEPHALOPATHY
ETIOLOGY AND PATHOGENESIS OF HYPOXIC-ISCHEMIC ENCEPHALOPATHY HYPOXIC-ISCHEMIC ENCEPHALOPATHY Hypoxic-İschemic Encephalopathy Encephalopathy due to hypoxic-ischemic injury [Hypoxic-ischemic encephalopathy
More informationClinical Competency Name: Post-operative use of Metaraminol in Recovery
Clinical Competency Name: Post-operative use of Metaraminol in Recovery Trainee name: Title: Ward or department: Method of assessment: Clinical assessor: Name: Title: Professional assessor: Name: Title:
More informationShould hypertensive disorders of pregnancy be considered as a prehypertension state?
February 2018 Should hypertensive disorders of pregnancy be considered as a prehypertension state? Pr. Jacques Blacher Paris-Descartes University ; AP-HP ; Unité HTA, prévention et thérapeutique cardio-vasculaires,
More informationPreterm Labour and Tocolysis
Title: CLINICAL GUIDELINES ID TAG Preterm Labour and Tocolysis Authors: Designation: Speciality / Division: Directorate: Dr L Bell, Dr K Price, Dr G McKeown, Mr D Sim Trainee, Trainee, CAH Consultant,
More informationCARDIAC ARREST IN SPECIAL CIRCUMSTANCES 2
CARDIAC ARREST IN SPECIAL CIRCUMSTANCES 2 M1 Objectives To understand how resuscitation techniques should be modified in the special circumstances of: Hypothermia Immersion and submersion Poisoning Pregnancy
More informationExample Clinician Educational Material for Providers of Immune Effector Cellular Therapy
Example Clinician Educational Material for Providers of Immune Effector Cellular Therapy Disclaimer: This example is just one of many potential examples of clinician education material that can be provided
More informationSHOCK AETIOLOGY OF SHOCK (1) Inadequate circulating blood volume ) Loss of Autonomic control of the vasculature (3) Impaired cardiac function
SHOCK Shock is a condition in which the metabolic needs of the body are not met because of an inadequate cardiac output. If tissue perfusion can be restored in an expeditious fashion, cellular injury may
More informationCMQCC PREECLAMPSIA TOOLKIT PREECLAMPSIA CARE GUIDELINES CDPH-MCAH Approved: 12/20/13 MAGNESIUM SULFATE
MAGNESIUM SULFATE CMQCC PREECLAMPSIA TOOLKIT Ocean Berg, RN, MSN, IBCLC, Nurse Family Partnership Program Richard H. Lee, MD, University of Southern California Brenda Chagolla, RN, MSN, CNS, University
More informationALS MODULE 7 Pharmacology
ALS MODULE 7 Pharmacology Relates to HLT404C Apply Advanced Resuscitation Techniques Introduction There are no studies that addressed the order of drug administration. There is inadequate evidence to define
More information"Women's Health" is also available at
"Women's Health" is also available at www.squarepharma.com.bd Vol-5 No-4 Oct-Dec 2012 Editorial Board Editorial Note: Dr. Omar Akramur Rab MBBS, FCGP, FIAGP Dear Doctor, Mohammad Hanif M. Pharm, MBA A.H.M.
More informationBirth Asphyxia - Summary of the previous meeting and protocol overview
Birth Asphyxia - Summary of the previous meeting and protocol overview Dr Ornella Lincetto, WHO Geneve Milano, 11June 2007 Vilka är Personality egenskaper med den astrologiska Tvillingarna? Objective of
More informationUK Obstetric Surveillance System. Myocardial Infarction Study 07/05 CASE. Data Collection Form - CASE
ID Number: Case Definition: UK Obstetric Surveillance System Myocardial Infarction Study 07/05 Data Collection Form - All women in the UK identified as having myocardial infarction during pregnancy or
More informationLEARNING OBJECTIVES 2/20/2017
HYPERTENSION IN PREGNANCY: PREVENTING SEVERE MATERNAL MORBIDITY & MORTALITY THROUGH THE IMPLEMENTATION OF EVIDENCED BASED PROTOCOLS Laura Senn, RN, PhD, CNS Sutter Medical Center, Sacramento LEARNING OBJECTIVES
More informationhttps://www.lucidoc.com/cgi/doc-gw.pl?ref=overlake_p:53602
Page 1 of 6 Protocol : Severe Hypertension in Obstetrics: Emergent Treatment DocID: 53602 Revision: 7 Status: Official Department: Women's and Infants' Admin Manual(s): Labor and Delivery Mother Baby Unit
More informationThe Effect of Valvular Heart Diseases on Maternal and Fetal Outcome of Pregnancy Nada Salih Ameen*,Nawfal Fawzi Anwer**
THE VALVULAR IRAQI POSTGRADUATE HEART DISEASES MEDICAL AND JOURNAL PREGNANCY The Effect of Valvular Heart Diseases on Maternal and Fetal Outcome of Pregnancy Nada Salih Ameen*,Nawfal Fawzi Anwer** ABSTRACT:
More informationTransfusion Requirements and Management in Trauma RACHEL JACK
Transfusion Requirements and Management in Trauma RACHEL JACK Overview Haemostatic resuscitation Massive Transfusion Protocol Overview of NBA research guidelines Haemostatic resuscitation Permissive hypotension
More information, Correlation between Neuroimaging and Clinical Presentation in Eclampsia
Correlation between Neuroimaging and Clinical Presentation in Eclampsia Krishna Dahiya, Mahesh Rathod, Seema Rohilla, Pushpa Dahiya Department of Obstetrics and Gynecology, Pt.BDS, PGIMS, Rohtak Email:
More informationEVALUATION OF THYROID FUNCTION IN PRE-ECLAMPSIA
EVALUATION OF THYROID FUNCTION IN PRE-ECLAMPSIA K. Sunanda 1, P. Sravanthi 2, H. Anupama 3 1Assistant Professor, Department of Obstetrics & Gynaecology, Gandhi Medical College/Hospital. 2Post Graduate,
More informationSurgical Care at the District Hospital. EMERGENCY & ESSENTIAL SURGICAL CARE
Surgical Care at the District Hospital 1 14 Practical Anesthesia Key Points 2 14.1 General Anesthesia Have a clear plan before starting anesthesia Never use an unfamiliar anesthetic technique in an emergency
More informationKofinas Perinatal Providing Care to the Unborn
Alexander D. Kofinas, MD Director, Kofinas Perinatal Associate Professor, Clinical Obstetrics and Gynecology Cornell University, College of Medicine Patient instructions for the use of Indomethacin and
More informationSupplemental Digital Content: Definitions Based on the International Classification of Diseases, Ninth Revision, Clinical Modification
Supplemental Digital Content: Definitions Based on the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) Diagnose and Procedures Codes 1. ICD-9-CM definition of
More informationGUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE
2018 UPDATE QUICK SHEET 2018 American Heart Association GUIDELINES FOR THE EARLY MANAGEMENT OF PATIENTS WITH ACUTE ISCHEMIC STROKE A Summary for Healthcare Professionals from the American Heart Association/American
More informationApproach to disseminated intravascular coagulation
Approach to disseminated intravascular coagulation Khaire Ananta Shankarrao 1, Anil Burley 2, Deshmukh 3 1.MD Scholar, [kayachikitsa] 2.Professor,MD kayachikitsa. 3.Professor and HOD,Kayachikitsa. CSMSS
More informationCARDIAC PROBLEMS IN PREGNANCY
CARDIAC PROBLEMS IN PREGNANCY LAS VEGAS, NEVADA, USA 27 February 1 March 2016 SUCCESSFUL TREATMENT WITH RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR OF MASSIVE PULMONARY EMBOLISM IN THE 16 TH WEEK OF PREGNANCY
More informationChapter 3 MAKING THE DECISION TO TRANSFUSE
Chapter 3 MAKING THE DECISION TO TRANSFUSE PRACTICE POINTS Determine the best treatment for the patient which may include transfusion. Treat the cause of cytopenia (anaemia or thrombocytopenia) or plasma
More informationResuscitation Fluids
Resuscitation Fluids Acceptable Fluids (also known as): Sodium Chloride Hartmann s Solution (Ringer-Lactate Solution, Compound Sodium Lactate) 4.5% Albumin Solution (PPS) Gelofusine 20ml/kg Bolus Can be
More informationCOMPANY CORE PACKAGE INSERT CCPI (PI/CORE/ENGLISH)
COMPANY CORE PACKAGE INSERT CCPI (PI/CORE/ENGLISH) HUMAN ALBUMIN 20 % BEHRING Rev.: 05-MAR-2008 / PEI approval 26.02.08 Supersedes previous versions Rev.: 28-NOV-2007 / Adaptation to Core SPC Rev.: 02-JAN-2007
More information